Chatsworth, Calif.
Respiratory manufacturer CHAD Therapeutics has named Earl L. Yager president and CEO. Previously president, CFO and secretary, Yager succeeds Thomas E. Jones, who had been CEO since 1998 and who will remain as chairman of the board.
“CHAD's board is pleased to name Earl Yager as chief executive officer, a position he is well-equipped to fill with distinction,” Jones said. “[Yager] has repeatedly demonstrated his leadership and effectiveness in managing the business. He has made critical contributions to our strategy to enhance CHAD's leadership in the conserver segment of the oxygen therapy market and to enter new growth markets in oxygen therapy and related fields. His efforts to increase manufacturing efficiency, improve margins and reduce costs also have met with success.”
Yager, a CPA, has served as president of the company since January of 2003.
The company also announced that Tracy Kern has been promoted to CFO, succeeding Yager at that position. Kern had been the company's cost accounting manager since she joined the manufacturer in January 2003.
For breaking news, go to www.homecaremonday.com, the electronic news service of the home medical equipment industry.
